Not all patients with CLL demand therapy. Irrespective of all recent innovations, the iwCLL still endorses watchful observation for clients with asymptomatic disorder.86 This advice relies on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each trials concluded that early https://christs641lta8.blogitright.com/profile